9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Tesaro, Inc.
DEKA Biosciences
Eli Lilly and Company
Cantargia AB
AHS Cancer Control Alberta
City of Hope Medical Center
Washington University School of Medicine